Zogenix to Release Third Quarter 2015 Financial Results and Host Conference Call & Webcast on November 9

SAN DIEGO, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. ZGNX, a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the third quarter ended September 30, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, November 9, 2015, at 4:30pm Eastern Time.

About Zogenix

Zogenix, Inc. ZGNX is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information, visit www.zogenix.com.